Cargando…
Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) has recently been proposed to replace non-alcoholic fatty liver disease and focus on patients with progressive disease due to the presence of metabolic dysfunction. However, it is unclear whether the new definition actually...
Autores principales: | Semmler, Georg, Balcar, Lorenz, Wernly, Sarah, Völkerer, Andreas, Semmler, Lorenz, Hauptmann, Laurenz, Wernly, Bernhard, Aigner, Elmar, Niederseer, David, Datz, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570507/ https://www.ncbi.nlm.nih.gov/pubmed/37842290 http://dx.doi.org/10.3389/fendo.2023.1244405 |
Ejemplares similares
-
Helicobacter pylori and cardiovascular risk: Only a dead Helicobacter is a good Helicobacter?
por: Wernly, Sarah, et al.
Publicado: (2022) -
Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related Mortality
por: Wernly, Sarah, et al.
Publicado: (2022) -
Diverticulosis and cardiometabolic risk factors: a systematic literature review
por: Völkerer, Andreas, et al.
Publicado: (2023) -
Machine Learning Models Cannot Replace Screening Colonoscopy for the Prediction of Advanced Colorectal Adenoma
por: Semmler, Georg, et al.
Publicado: (2021) -
sST2 Levels Show No Association with Helicobacter pylori Infection in Asymptomatic Patients: Implications for Biomarker Research
por: Wernly, Sarah, et al.
Publicado: (2023)